Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Operating Expenses | 4,651 | 3,839 | 4,273 | 3,365 | 2,461 |
| Operating Income | -4,651 | -3,839 | -4,273 | -3,365 | -2,461 |
| Other Income | 95 | 1 | 48 | -3 | -36 |
| Pre-tax Income | -4,556 | -3,838 | -4,225 | -3,368 | -2,497 |
| Net Income Continuous | -4,556 | -3,838 | -4,225 | -3,368 | -2,497 |
| Net Income | $-4,556 | $-3,838 | $-4,226 | $-3,368 | $-2,497 |
| EPS Basic Total Ops | -699.30 | -611.89 | -699.30 | -699.30 | -524.48 |
| EPS Basic Continuous Ops | -681.31 | -575.22 | -773.01 | -659.30 | -488.80 |
| EPS Diluted Total Ops | -699.30 | -611.89 | -699.30 | -699.30 | -524.48 |
| EPS Diluted Continuous Ops | -681.31 | -575.22 | -773.01 | -659.30 | -488.80 |
| EBITDA(a) | $-4,647 | $-3,836 | $-4,263 | $-3,355 | $-2,449 |